GW Henssler & Associates’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.2M | Sell |
125,512
-3,551
| -3% | -$544K | 0.9% | 42 |
|
|
2025
Q4 | $17.8M | Sell |
129,063
-4,405
| -3% | -$577K | 0.86% | 50 |
|
|
2025
Q3 | $17.1M | Sell |
133,468
-1,938
| -1% | -$236K | 0.86% | 45 |
|
|
2025
Q2 | $16.4M | Sell |
135,406
-1,012
| -0.7% | -$114K | 0.88% | 49 |
|
|
2025
Q1 | $15.2M | Sell |
136,418
-110,378
| -45% | -$11.8M | 0.87% | 54 |
|
|
2024
Q4 | $28.4M | Sell |
246,796
-4,082
| -2% | -$435K | 1.63% | 20 |
|
|
2024
Q3 | $28.9M | Buy |
250,878
+1,653
| +0.7% | +$188K | 1.63% | 20 |
|
|
2024
Q2 | $26.5M | Buy |
249,225
+599
| +0.2% | +$60.1K | 1.6% | 21 |
|
|
2024
Q1 | $24M | Buy |
248,626
+1,400
| +0.6% | +$144K | 1.41% | 26 |
|
|
2023
Q4 | $25M | Buy |
247,226
+10,391
| +4% | +$1M | 1.65% | 20 |
|
|
2023
Q3 | $24.1M | Sell |
236,835
-343
| -0.1% | -$34.8K | 1.65% | 18 |
|
|
2023
Q2 | $23.9M | Sell |
237,178
-188,711
| -44% | -$18.9M | 1.57% | 22 |
|
|
2023
Q1 | $39.2M | Buy |
425,889
+7,201
| +2% | +$629K | 2.6% | 5 |
|
|
2022
Q4 | $38M | Buy |
418,688
+7,857
| +2% | +$662K | 2.67% | 6 |
|
|
2022
Q3 | $31.2M | Buy |
410,831
+28,523
| +7% | +$2.36M | 2.34% | 7 |
|
|
2022
Q2 | $32.3M | Buy |
382,308
+156,187
| +69% | +$13.7M | 2.4% | 7 |
|
|
2022
Q1 | $19.8M | Buy |
226,121
+17,967
| +9% | +$1.56M | 1.21% | 31 |
|
|
2021
Q4 | $18.2M | Sell |
208,154
-724
| -0.3% | -$60.1K | 1.16% | 34 |
|
|
2021
Q3 | $17.1M | Buy |
208,878
+12,251
| +6% | +$1.1M | 1.18% | 36 |
|
|
2021
Q2 | $17.9M | Buy |
196,627
+7,664
| +4% | +$682K | 1.18% | 34 |
|
|
2021
Q1 | $16.2M | Buy |
188,963
+8,558
| +5% | +$768K | 1.16% | 35 |
|
|
2020
Q4 | $17M | Buy |
180,405
+2,780
| +2% | +$243K | 1.3% | 32 |
|
|
2020
Q3 | $15.4M | Buy |
177,625
+5,774
| +3% | +$500K | 1.31% | 30 |
|
|
2020
Q2 | $15M | Buy |
171,851
+14,645
| +9% | +$1.26M | 1.32% | 35 |
|
|
2020
Q1 | $13M | Buy |
157,206
+39,354
| +33% | +$3.51M | 1.31% | 38 |
|
|
2019
Q4 | $11.2M | Buy |
117,852
+7,090
| +6% | +$636K | 0.92% | 47 |
|
|
2019
Q3 | $9.63M | Buy |
110,762
+2,223
| +2% | +$200K | 0.86% | 50 |
|
|
2019
Q2 | $9.91M | Buy |
108,539
+287
| +0.3% | +$24.3K | 0.9% | 49 |
|
|
2019
Q1 | $9.33M | Buy |
108,252
+1,783
| +2% | +$143K | 0.85% | 53 |
|
|
2018
Q4 | $8.19M | Buy |
106,469
+4,665
| +5% | +$363K | 0.87% | 51 |
|
|
2018
Q3 | $7.86M | Buy |
101,804
+3,265
| +3% | +$241K | 0.72% | 56 |
|
|
2018
Q2 | $6.67M | Buy |
98,539
+5,431
| +6% | +$375K | 0.65% | 57 |
|
|
2018
Q1 | $6.75M | Buy |
93,108
+2,137
| +2% | +$163K | 0.68% | 57 |
|
|
2017
Q4 | $6.84M | Buy |
90,971
+5,297
| +6% | +$400K | 0.64% | 60 |
|
|
2017
Q3 | $6.59M | Buy |
85,674
+5,829
| +7% | +$440K | 0.66% | 60 |
|
|
2017
Q2 | $5.97M | Buy |
79,845
+4,952
| +7% | +$351K | 0.62% | 62 |
|
|
2017
Q1 | $4.98M | Buy |
74,893
+13,332
| +22% | +$888K | 0.54% | 65 |
|
|
2016
Q4 | $4.02M | Sell |
61,561
-1,685
| -3% | -$109K | 0.44% | 68 |
|
|
2016
Q3 | $4.47M | Buy |
63,246
+2,447
| +4% | +$178K | 0.51% | 65 |
|
|
2016
Q2 | $4.5M | Buy |
60,799
+6,951
| +13% | +$480K | 0.52% | 65 |
|
|
2016
Q1 | $3.5M | Buy |
53,848
+5,079
| +10% | +$346K | 0.41% | 71 |
|
|
2015
Q4 | $3.76M | Sell |
48,769
-7,900
| -14% | -$628K | 0.44% | 69 |
|
|
2015
Q3 | $4.67M | Buy |
56,669
+1,939
| +4% | +$173K | 0.54% | 69 |
|
|
2015
Q2 | $4.82M | Buy |
54,730
+1,803
| +3% | +$165K | 0.52% | 70 |
|
|
2015
Q1 | $4.68M | Buy |
52,927
+564
| +1% | +$50K | 0.54% | 51 |
|
|
2014
Q4 | $4.35M | Buy |
52,363
+119
| +0.2% | +$9.86K | 0.49% | 65 |
|
|
2014
Q3 | $4.41M | Buy |
52,244
+3,021
| +6% | +$244K | 0.53% | 60 |
|
|
2014
Q2 | $3.99M | Sell |
49,223
-2,381
| -5% | -$187K | 0.48% | 62 |
|
|
2014
Q1 | $3.93M | Sell |
51,604
-6,658
| -11% | -$485K | 0.46% | 66 |
|
|
2013
Q4 | $4.2M | Sell |
58,262
-744
| -1% | -$51.7K | 0.49% | 52 |
|
|
2013
Q3 | $4.06M | Sell |
59,006
-432
| -0.7% | -$28.6K | 0.52% | 51 |
|
|
2013
Q2 | $3.77M | Buy |
+59,438
| New | +$3.87M | 0.52% | 47 |
|
Other funds holding NVS
GW Henssler & Associates's NVS Position: Q1 2026 in Review
GW Henssler & Associates reduced its Novartis (NVS) stake by 2.8% in Q1 2026, selling an estimated $544K and leaving 125,512 shares worth $19.2M. The position accounts for 0.9% of the portfolio, ranked #42.
GW Henssler & Associates first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $39.2M in Q1 2023. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- GW Henssler & Associates held 125,512 shares of Novartis worth $19.2M as of Q1 2026.
- GW Henssler & Associates sold 3,551 Novartis shares in Q1 2026, an estimated $544K.
- Novartis made up 0.9% of GW Henssler & Associates's portfolio in Q1 2026, its #42 holding.
- GW Henssler & Associates first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- GW Henssler & Associates's Novartis position peaked at $39.2M in Q1 2023.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on GW Henssler & Associates's 13F filing for Q1 2026, filed 15 May 2026.